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Transplantation of endothelial cells onto a prosthet-
ic material to act as a nonthrombogenic barrier
between the blood and the foreign material was
conceived as a potential means of overcoming these
high failure rates.1 To date, however, the clinical
efficacy of endothelial cell transplantation has not
been established through a multicenter clinical trial.
One reason for this failure may be the high loss of
endothelial cells at implantation (up to 30% over
the first 30 minutes), which leaves the graft nonen-
dothelialized and negates the theoretical benefits of
endothelial cell transplantation.2 Thus it has never
been possible to evaluate whether endothelial cell
transplantation is clinically useful or beneficial.
Previous endothelial cell transplantation tech-
niques (with use of gravitational and hydrostatic
forces) required an incubation period before implan-
tation of the graft to minimize loss of cells at expo-
sure to shear stress.3,4 One requirement for the incu-
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The success of synthetic materials as small-diam-
eter (<6 mm) arterial bypass grafts tends to be
problematic because of low graft patency rates.
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bation period is that morphologic maturation of the
negatively charged endothelial cells, assessed accord-
ing to degree of flattening, progresses slowly on
negatively charged graft materials (expanded polyte-
trafluoroethylene; ePTFE) because of natural repul-
sive forces.5,6 The amount (cell number) of adhesion
is reduced by electrostatic repulsive forces between
the cells and the graft. Despite progress in endothe-
lial cell transplantation, limitations exist, including
the repulsive force between the graft and the cells.
The electrostatic transplantation technique was
developed to promote endothelial cell attraction to
the graft by means of inducing a “temporary” posi-
tive, or less negative, graft luminal surface charge.7,8
When the graft is removed from the electrostatic
transplantation device, the luminal surface charge
immediately reverts to its natural negative state, ren-
dering any nonendothelialized areas nonthrombo-
genic. Results of a previous study indicated that a
temporary positive surface charge increased the total
number of adherent transplanted endothelial cells
and accelerated their morphologic maturation, all
within a clinically acceptable transplantation time of
16 minutes (G. L. B., unpublished data, 1997).
The purpose of this study was to determine
whether electrostatic endothelial cell transplanta-
tion (+1.0 V/16 min) affects (1) retention of trans-
planted human umbilical vein endothelial cells
(HUVEC) on the graft during exposure to physio-
logic shear stress (15 dynes/cm2) compared with
gravitational transplantation (0.0 V/16 min) and
(2) production of prostacyclin (PGI2) and throm-
boxane A2 (TxA2) by HUVEC compared with grav-
itational transplantation.
METHODS
Cell culture. The HUVECs (Clonetics Corp.)
used were from a single donor and cultured at 37° C,
5% carbon dioxide, and constant humidity through
two passages. The HUVECs were maintained in
endothelial growth medium composed of endothelial
basal media (Clonetics), SingleQuots medium
(Clonetics), and 2% fetal bovine serum (FBS) (Sigma
Chemical Co.). The SingleQuots medium consisted
of 10 m g/ml (0.5 ml) human recombinant epidermal
growth factor, 1.0 mg/ml (0.5 ml) hydrocortisone,
0.5 ml gentamicin (50 mg/ml), amphotericin-B (50
m g/ml), and 2.0 ml bovine brain extract with 10
m g/ml heparin. The final component of the endothe-
lial growth medium was the addition of a 1.25%
(vol.) penicillin-streptomycin-fungizone mixture
(BioWhittaker, Inc.) composed of penicillin 10,000
units/ml, streptomycin 10,000 units/ml, and fungi-
zone 25 m g/ml.
Cell harvest and resuspension. The HUVECs
were harvested from the tissue culture flask by
means of removal of the endothelial growth medi-
um and rinsing with 5 ml HEPES buffered saline
solution (Clonetics). Four milliliters of trypsin–eth-
ylenediaminetetraacetic acid (EDTA) (0.025%
trypsin; Clonetics) was added to the flask for 7 min-
utes at 37° C after which 4 ml of trypsin neutraliz-
ing solution (Clonetics) was added. The resulting
HUVEC suspension (~8 ml) was transferred to a 15
ml centrifuge tube and centrifuged (110g) for 8.0
minutes. The pellet was resuspended (5 · 106
HUVEC/ml) in Dulbecco’s phosphate buffered
saline (DPBS) solution containing antioxidants (1.3
· 10–3 M dimethyl sulfoxide, 1 · 10-4 M sodium
ascorbate, and 3.6 · 10–5 M glutathione) to protect
the cellular membranes from free radicals during
transplantation.9
HUVEC transplantation. The HUVEC trans-
plantation device and general procedure (U.S. Patent
no. 5,714,359) used in this study have been described
previously.8 The electrostatic transplantation proce-
dure begins with placement of the internal conductor
of the device within the graft. The ends of the graft
are sealed with Sylgard plugs, which are formed
around the internal conductor to fit within the graft
lumen. The graft filled with the endothelial cell sus-
pension is transferred to the external conductor (303
stainless steel round), which is bored centrally to
match the external diameter of the graft. An electrical
potential is applied across the internal and external
conductor (cylindrical capacitor) to induce a positive
(less negative) luminal surface charge on the vascular
prosthesis (dielectric material within the capacitor).
The optimum applied voltage–transplantation time
combination for use of the prototype apparatus and
HUVECs was previously determined to be +1.0 volt
for 16 minutes (G. L. B., unpublished data, 1997).
The gravitationally seeded grafts were handled exact-
ly as the electrostatically seeded ones with the excep-
tion of no applied voltage across the conductors 
(0.0 V/16 min).
Physiologic shear stress exposure. The in vitro
flow loop evaluation exposed the HUVECs trans-
planted onto 6.0 cm segments of 4.0 mm internal
diameter (ID) ePTFE (Gore-Tex; W.L. Gore &
Associates) to a shear stress of 15 dynes/cm2, com-
parable with an average shear stress in the femoral
artery.10 The flow loop system (Fig. 1) met all the
requirements for Poiseuille flow. It consisted of a
variable speed, dual head, three roller, tubing pump
(Model 7520-00, Masterflex L/S; Cole-Parmer
Instrument Co.) with standard Masterflex pump
heads; C-flex tubing (size 15) (Cole-Parmer); com-
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pliance chamber; entrance tubing; tubing/graft
couplers; graft/DPBS chambers; and effluent tub-
ing. The in vitro flow loop system was composed of
parallel components to allow direct comparison of
the electrostatically seeded grafts with the controls.
The circulating fluid consisted of Medium-199
(Gibco Life Technologies), 20% FBS (Sigma), and
1.25% penicillin-streptomycin-Fungizone mixture
(BioWhittaker, Inc.). The flow loop system was cal-
ibrated with the time-collection method to a flow
rate of 376.2 ± 6.6 ml/min, which corresponded
with a calculated wall shear stress (4 m Q/ p R3) of
15.2 ± 0.2 dynes/cm2.11 The entire flow loop sys-
tem with the exception of the pump was housed in
an incubator and maintained at 37° C, 5% carbon
dioxide, and constant humidity.
The in vitro flow loop experimental design con-
sisted of comparing the cell retention of the opti-
mum electrostatic transplantation (+1.0 V/16
min) with that of gravitational transplantation (0.0
V/16 min) of HUVECs at shear stress exposure
times of 0, 30, and 120 minutes. The grafts not
exposed to shear stress (0 minutes) were analyzed
immediately after seeding and not attached to the
in vitro flow loop system. The 0.0 V/16 min con-
trol was an a priori condition used to match the
gravitational transplantation (0.0 V) time with that
of the optimum electrostatic transplantation. The
number of replications for each test condition was
eight (n = 8).
Immediately after shear stress exposure, two 4
mm biopsy specimens were taken from the central
region of each graft and placed in 0.1 ml of 0.025%
trypsin/EDTA (Clonetics) in separate centrifuge
tubes at 37° C. After 3 minutes, 0.1 ml of crystal-
violet stain was added to each tube. The total num-
ber of HUVECs was determined with a hemocy-
tometer and converted to HUVEC retention density
by means of division of the biopsy surface area (0.183
cm2). The complete HUVEC retention data set was
examined statistically (significance level a = 0.05) by
means of two-way analysis of variance (ANOVA)
with the Statistical Analysis System (SAS) (SAS
Institute, Inc.) followed by a Student-Neuman-Keuls
post priori test of the means to determine when a dif-
ference may have existed between transplantation
techniques and shear stress exposure times.
Biochemical assays. In vitro biochemical assays
(gravitational versus optimum electrostatic) were
conducted after HUVECs were transplanted onto
4 cm segments of 4 mm ID ePTFE. The purpose
of the biochemical assays was to evaluate whether
electrostatic transplantation (n = 12) had an
adverse effect on the HUVECs measured on the
basis of PGI2 and TxA2 production compared with
gravitational transplantation of HUVECs (n = 12)
on untreated grafts. Two random 4.0 mm biopsy
specimens were taken from each graft immediately
after seeding. The rationale for the immediate
biopsies was to determine whether electrostatic
HUVEC transplantation produced a thrombogenic
graft (high TxA2 levels with low PGI2 levels). The
biopsy specimens were placed in 1.0 ml of
Medium-199 with 10% FBS in 2.0 ml tissue culture
wells. A third tissue culture well (control) con-
tained Medium-199 and 10% FBS. The biopsy
specimens were incubated at 37° C and 5% carbon
dioxide for 10 minutes. 
The medium from each tissue culture well was
transferred into a cryovial and maintained at –80° C
until radioimmunoassay for production of the stable
metabolites 6-keto-PGF1 a and TxB2 for PGI2 and
TxA2 could be performed. Iodinated (125I) radioim-
munoassay kits were used to determine the produc-
tion of PGI2 (6-keto-PGF1a , RPA 515; Amersham
Life Sciences) and TxA2 (TxB2, RPA 516; Amersham
Life Sciences) and the supplied radiolabeled standards
of 6-keto-PGF1a [125I] iodotyrosine methyl ester and
TxB2 [125I] iodotyrosine methyl ester in ethanol. All
radioimmunoassay evaluations were performed in
duplicate (n = 2). The radioactivity of each tube was
determined with a gamma counter (1480 Wizard 3”
Gamma Counter; Wallac, EG&G Co.), which was
preset to measure the counts per minute for 2 min-
utes. The background count was determined by
means of measuring the counts per minute of a blank
chamber over a 600 second period. The biochemical
Fig. 1. Schematic of one channel of the in vitro flow loop
system. The entire system (with the exception of the vari-
able speed roller pump) was housed in an incubator at 37°
C, 5% CO2, and constant humidity. The circulating fluid
was composed of Medium-199, 20% fetal bovine serum,
and 1.25% penicillin-streptomycin-Fungizone mixture.
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assay data were examined statistically with one-way
ANOVA (SAS) to determine whether significant dif-
ferences existed between the transplantation tech-
niques and the control at a level of a = 0.05.
RESULTS
Cellular retention. The results of the in vitro
retention evaluation are presented in Fig. 2 with
eight samples (n = 8) in each test condition. The
grafts subjected to gravitational transplantation had
an initial HUVEC transplantation density of 49,389
± 8720 HUVEC/cm2. After 30 minutes of exposure
to the physiologic shear stress (15 dynes/cm2), the
surface density of the gravitationally transplanted
HUVECs on the graft was significantly (a = 0.05)
reduced to 34,973 ± 4213 HUVEC/cm2. The
HUVEC surface density after 120 minutes of physi-
ologic shear stress exposure was 34,427 ± 4637
HUVEC/cm2, which was significantly different (a =
0.05) from the initial transplantation density but not
significantly different (a = 0.05) from the HUVEC
surface density after 30 minutes of physiologic shear
stress. The total gravitational HUVEC loss over the
first 30 minutes of physiologic shear stress exposure
was 29.2% with a 30.3% loss after 120 minutes of
physiologic shear stress exposure.
The results for the grafts subjected to optimum
electrostatic transplantation showed an average ini-
tial HUVEC transplantation density of 73,540 ±
8514 HUVEC/cm2. After 30 minutes of exposure
to physiologic shear stress, the electrostatic HUVEC
surface coverage density was 69,949 ± 5203
HUVEC/cm2, which was significantly different (a =
0.05) from that of grafts subjected to gravitational
transplantation but not significantly different from
densities before flow exposure. After 120 minutes of
physiologic shear stress exposure, the HUVEC sur-
face coverage density was 78,420 ± 6274
HUVEC/cm2. Again, this was significantly different
(a = 0.05) from that of grafts subjected to gravita-
tional transplantation but not significantly different
from the HUVEC surface density of electrostatical-
ly seeded grafts at no flow or after 30 minutes of
shear stress exposure. Thus the overall result was no
significant loss ( a = 0.05) of HUVECs from the
grafts subjected to electrostatic transplantation on
exposure to physiologic shear stress for up to 120
minutes. Furthermore, the grafts subjected to elec-
trostatic transplantation had 2.3 times as many
HUVECs as the control grafts after 120 minutes of
exposure to shear stresses of 15 dynes/cm2.
Biochemical assays. Concentrations of 6-keto-
PGF1a in the culture medium for control and biopsy
specimens of gravitationally and electrostatically
transplanted HUVECs after the 10 minute incuba-
tion period are shown in Fig. 3. The culture medium
alone contained 4.34 ± 2.11 pg/ml (n = 6) 6-keto-
PGF1a . Biopsy media for gravitationally transplanted
HUVECs contained 5.31 ± 2.10 pg/ml (n = 12) of
6-keto-PGF1a , which was not significantly different
( a = 0.05) from the control value. Graft biopsy
media for electrostatically transplanted HUVECs
contained 6.14 ± 1.89 pg/ml (n = 12) of 6-keto-
PGF1a , which also did not differ from the control
value (a = 0.0508) or the value for the gravitational
transplantation biopsy specimens ( a = 0.05).
The concentration of TxB2 in the control and
biopsy media for the gravitationally and electrostati-
cally transplanted HUVECs after the 10 minute
incubation period are shown in Fig. 3. The control
medium TxB2 levels were 367.2 ± 109.5 pg/ml (n
= 6). The media from the gravitational transplanta-
tion biopsy specimens contained 329.1 ± 112.1
pg/ml (n = 12) of TxB2, which was not significant-
ly different (a = 0.05) from the control value. The
media from optimal electrostatic transplantation
biopsy specimens contained 297.0 ± 89.8 pg/ml (n
= 12) of TxB2, which was not significantly different
(a = 0.05) from either the control value or the value
for gravitational transplantation biopsy media.
DISCUSSION
Patency rates of small diameter synthetic vascular
prostheses fail to match those of autologous vessel
grafts (internal mammary artery or saphenous vein)
when used clinically. As previously discussed, the
concept of endothelial cell transplantation was
developed as a potential treatment to overcome fail-
Fig. 2. In vitro endothelial cell retention (HUVEC/cm2)
after exposure to a shear stress of 15 dynes/cm2 (mean
value ± SD) (n = 8).
The likelihood of an increase in patency rate of
small diameter vascular prostheses subjected to elec-
trostatic endothelial cell transplantation is based on
the results of multiple studies.3,12-16 First, there is
no clear evidence to indicate that endothelial cell
transplantation of small diameter (<6 mm) vascular
prostheses significantly increases the thromboresis-
tance of vascular prostheses.12-16 Second, the depen-
dence of cellular retention on morphologic matura-
tion was demonstrated by Pratt et al.3 Those inves-
tigators found that endothelial cell retention at
exposure to shear stress increased with culture time
(time to morphologic maturity) before implanta-
tion. Conversely, a study by Herring et al.16 showed
failure of low-density seeding to increase patency of
small diameter vascular prostheses (ePTFE) com-
pared with untreated grafts, because the endothelial
cells had a spherical (rounded) morphologic config-
uration. Thus the electrostatically accelerated mor-
phologic maturation (degree of flattening) may pro-
vide for increased patency rates compared with other
available endothelial cell transplantation techniques.
Finally, a study by Douville et al.15 indicated that
endothelial cell seeding significantly increased long-
term patency rates of small diameter ePTFE vascular
prostheses. Future in vivo evaluations are necessary
to determine the thromboresistance and long-term
patency rates of ePTFE vascular prostheses subject-
ed to electrostatic transplantation.
For endothelial cell transplantation to be em-
braced by surgeons, a minimal amount of time must
be used to obtain luminal coverage of transplanted
endothelial cells. There is considerable debate over a
clinically acceptable transplantation time with 2 hours
or less appearing to be clinically acceptable.17 A time
greater than 2 hours would not be acceptable to most
surgeons because of the possibility of genotype or
phenotype changes from cellular exposure to an
undefined medium-containing serum.17 It should be
noted that transplantation time does not include har-
vesting of endothelial cells from the autologous
source, which can take approximately 45 minutes
depending on the method. On the basis of the expe-
rience in this study, the combination of endothelial
cell harvesting and electrostatic transplantation would
take approximately 60 minutes.
Seeding techniques have been developed that
make use of the microporosity (forced deposition) of
vascular prostheses for transplantation of endothelial
cells on the graft luminal surface in a matter of min-
utes.4,18 An excellent example of this type of tech-
nique is the vacuum cell seeding technique whereby
evenly distributed, luminal cell coverage was obtained
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ure of vascular prostheses. The ultimate goal of
long-term patency of vascular prostheses subjected
to endothelial cell transplantation has not been
achieved because of a number of potential technical
issues. These issues include inefficient endothelial
cell harvesting (low number of endothelial cells for
transplantation), poor cell attachment, and subse-
quent lack of retention at implantation of the trans-
planted prostheses. As the data of this study show,
electrostatic endothelial cell transplantation provides
a means of overcoming each of these limitations.
Enhanced endothelial cell adhesion and accelerated
morphologic maturation (flattening) (G. L. B.,
unpublished data, 1997) resulted in no cellular loss
on physiologic shear stress exposure up to 120 min-
utes, a time at which the bulk of endothelial cell loss
would be expected.2 This increased cellular reten-
tion also may reduce the initial need for large num-
bers of transplanted endothelial cells. 
Fig. 3. Prostacyclin (PGI2) (top) and thromboxane
(TxA2) (bottom) production expressed as the stable
metabolites 6-keto-PGF1a (pg/ml) and TxB2 (pg/ml) in
Medium-199 and 10% FBS after a 10 minute incubation,
respective (mean value ± SD). The number of replications
for each set of samples was 12 (n = 12) except for controls
(n = 6).
in 10 minutes.4 However, the endothelial cells were
spheroid with minimal attachment to the graft mate-
rial. It is speculated that if this graft were to be
implanted immediately after seeding, most of the cells
would be lost from the luminal surface. The study also
showed that the cells did flatten on the surface after a
2 hour incubation period.4 The other important lim-
itation of this type of technique is that it requires
microporous grafts, limiting the choice of material.
The electrostatic technique, however, can be applied
to any nonconductive graft material, nonporous or
porous.
Many endothelial cell transplantation techniques
have been used in attempts to increase the number of
endothelial cells that adhere to synthetic graft mate-
rials and to enhance morphologic maturation by
means of placing adhesive proteins (i.e., fibronectin)
on the graft luminal surface to act as a “glue”.18-21
The glues enhance endothelial cell adhesion and
morphologic maturation, but because of a small
number of cells, the surface may not be completely
endothelialized or cells may be lost at flow exposure,
rendering the graft surface thrombogenic. The
advantage of the electrostatic transplantation tech-
nique is that enhanced attachment of HUVEC is
induced through a temporary positive surface charge
or a “temporary glue.” After electrostatic transplan-
tation, the ePTFE graft luminal surface reverts to the
original highly negatively charged surface. Thus we
speculate that any surface that is nonendothelialized
or exposed because of endothelial cell losses remains
as nonthrombogenic as before.
Endothelial cell seeding density was 73,540 ±
8514 HUVEC/cm2 for the electrostatically seeded
grafts. This is a low seeding density (subconfluent),
but it is essentially the maximum that can be
achieved during the electrostatic seeding procedure.
This is because of phenomena within the apparatus
(electric field intensification at the nodal edges of
the graft material) that restrict endothelial cell adhe-
sion to the nodal areas of the ePTFE graft luminal
surface. Considering the small total nodal surface
area of ePTFE, it has been shown (G. L. B., unpub-
lished data, 1997) that a confluent, nodal area cov-
erage (maximum transplantation density) is obtained
with electrostatic endothelial cell seeding. It is spec-
ulated that larger seeding or sodding densities would
be achieved with increased surface area available for
adhesion. It is also speculated that improved cellular
retention will outweigh low initial seeding density in
terms of thromboresistance, to be determined with
future in vivo evaluations.
Endothelial cell seeding density was determined
through cell count of HUVECs that adhered to the
graft luminal surface. Initially, the cell densities were
to be determined through scanning electron micro-
scopic examination and acquisition of cellular mor-
phologic data. Because of the high confluence of cel-
lular adhesion on the nodal areas of the ePTFE, the
cells were difficult to differentiate from one another;
thus manual cell counting was necessary to obtain
the cellular surface densities.
The rationale for evaluating HUVEC production
of PGI2 and TxA2 was based on the importance of
these components with endothelial cell antithrombo-
genic properties. There was concern that electrostat-
ic endothelial cell transplantation would alter the
nonthrombogenic balance (PGI2/TxA2 ratio) of
normal endothelial cells. Ingerman-Wojenski et al.22
showed that bovine endothelial cells in culture pro-
duce 5 to 10 times more PGI2 than TxA2. A similar
study by Bush et al.23 of PGI2 and TxA2 production
in canine iliac arteries indicated that basal production
of PGI2 (6-keto-PGF1a ) and TxA2 (TxB2) resulted
in a 6-keto-PGF1 a /TxB2 ratio of 20.7 ± 3.5. To
maintain antithrombogenicity after endothelial cell
transplantation onto a synthetic material, a similar
balance of PGI2 and TxA2 is desirable.
Although our results showed that electrostatic
transplantation of HUVECs increased PGI2 produc-
tion did not reach statistical significance, the tenden-
cy is consistent with results of a study by Eldor et
al.24 They showed that rapidly growing bovine aortic
endothelial cells produced significantly less PGI2
than confluent, nondividing endothelial cells. Their
study also showed no significant production of TxA2
by endothelial cells, which is consistent with the
results reported herein. Thus the higher morpholog-
ic maturation level of HUVECs after electrostatic
transplantation may cause lower TxB2 production
and a tendency for increasing 6-keto-PGF1a produc-
tion. A slight increase in 6-keto-PGF1a production in
our study is further evidence to support the specula-
tion that electrostatic transplantation leads to
enhanced endothelial cell morphologic maturation.
The level of significant difference for the comparison
of the control biopsy specimens versus the specimens
subjected to optimal electrostatic transplantation was
p = 0.0508, which indicates that the difference
between the two compounds was very close to being
significant at the a priori level of a = 0.05. We spec-
ulate that a slightly longer incubation period may not
have achieved a statistical difference because of the
low HUVEC surface density (nonconfluent) and
corresponding minimal PGI2 production, following
the results of Eldor et al.24
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Two limitations of this in vitro study were the
use of cultured HUVECs and evaluation of cellular
retention at a single shear stress exposure. The use
of cultured cells raises many questions, including
questions about cell surface characteristics caused
by excessive handling and exposure to trypsin and
other media. This study was controlled for varia-
tions caused by these factors through the use of
HUVECs, endothelial growth medium, and trypsin
from a single lot and through identical handling of
cells during the culture and harvesting periods. The
use of other, noncultured cell lines (i.e., microvas-
cular endothelial cells) is speculated to achieve sim-
ilar results as the use of HUVECs. Further experi-
mental evaluation is required for each cell line to
verify this speculation. The shear stress used in this
study (15 dynes/cm2) represents the value expect-
ed in the femoral artery, which would be a prime
candidate for the use of a 4 mm graft.10 Another
option that merits future evaluation is placement of
these grafts under higher shear stresses (>50
dynes/cm2) as commonly seen in an arteriovenous
(access) fistula.
Another way of looking at the temporary glue
aspect of the electrostatic endothelial cell seeding
procedure is to refer to wettability (classic measure
of surface charge). Wettability can be determined
on the basis of contact angle measurements of liq-
uids (H2O) on a surface.25 A wettable surface has a
positive surface charge and attracts molecules of a
water droplet to the surface. Inversely, a negatively
charged surface repels water molecules from the
surface, which maintains the spheroid shape of the
water droplet. Thus in terms of the electrostatic
seeding procedure, the wettability of the surface is
increased temporarily during the procedure. This
state reverts back to natural wettability as soon as
the electrical potential is removed from the appara-
tus, because removal of the dipoles on the mole-
cules near the surface of the material leads to alter-
ation of wettability. Future experiments are needed
to examine the wettability aspect of the electrostat-
ic seeding procedure.
The other concern in terms of temporary surface
wettability is adsorption of any serum proteins on
the surface to permanently alter wettability. The
amount of serum proteins in the seeding suspension
would be minimal (except added albumin in DPBS)
because of processing of the HUVEC before seeding
and resuspension in DPBS. The albumin may be
adsorbed on the luminal surface of the graft, but it
has been shown not to enhance endothelial cell
adhesion compared with an untreated surface.26
JOURNAL OF VASCULAR SURGERY
510 Bowlin et al. March 1998
Thus it is speculated that adsorption of albumin on
the graft luminal surface would have a minimal affect
on wettability (surface charge).
CONCLUSIONS
The results of this study showed that electrostatic
transplantation of HUVECs significantly increased (a
= 0.05) cellular retention at physiologic shear stress
exposure compared with gravitational transplantation
on untreated ePTFE grafts. The grafts subjected to
gravitational transplantation (0.0 V/16 min) experi-
enced a 29.2% loss of HUVECs after 30 minutes of
exposure to a physiologic shear stress of 15 dynes/cm2
with no further significant (a = 0.05) loss after 120
minutes of shear stress exposure. The grafts subjected
to optimal electrostatic transplantation (+1.0 V/16
min), however, had no significant loss (a = 0.05) of
HUVECs after 30 and 120 minutes of physiologic
shear stress exposure. Electrostatic HUVECs trans-
plantation did not significantly (a = 0.05) affect cellu-
lar production of PGI2 and thromboxane A2 com-
pared with gravitational transplantation on untreated
ePTFE grafts nor did optimally electrostatically and
gravitationally transplanted HUVECs show any signif-
icant production difference (a = 0.05) compared with
controls (Medium-199 and 10% FBS).
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